2nd Biophysical Summit
Join us for the 2nd Biophysical Summit - Exploring New Peaks in Biophysical Characterisation Hosted by KBI and Applied Photophysics.
Join Applied Photophysics and KBI Biopharma for an interactive workshop to discuss best practices for Biophysical Characterization. Hear from recognized experts about critical regulatory expectations and the best practices for the characterization of higher order structure of molecules. This summit will highlight some of the latest analytical techniques for developing and characterizing protein and gene therapies. Come with your questions and learn how companies tackle the characterization of novel modalities.
Highlights
John Carpenter: Mechanisms of aggregation and stabilization
Karl Maulf: How to Identify and Quantify Adeno-Associated Virus Fill States Using Analytical Ultracentrifugation
Please contact Camilla Hick at cam.hick@photophysics.com or 412-999-8649 for additional information. Don't pass up this fantastic chance to learn new things and connect with top biophysical characterisation experts.
Limited free registration is available! Register now! Join us in-person or Virtual...
Register Here
Agenda
9:00-9:30 Breakfast Reception
9:30 - 10:30 Talk: How to Identify and Quantify Adeno-Associated Virus Fill States Using Analytical Ultracentrifugation.
Karl Maluf - Director of Analytical Services, KBI Biopharma
10:30- 11:30 Talk: Breakthrough CD & FTIR Analysis for mAbs, ADCs and AAV’s
Rina Dukor - President & Co-Founder, BioTools, Inc.
11:30 - 12:30 Talk: Mechanisms of Aggregation and Stabilization.
John Carpenter - Professor Emeritus of Pharmaceuticals Sciences, University of Colorado, School of Pharmacy.
12:30 - 1:30 Lunch
1:30- 2:30 Talk: Controlling the chaos: Allosteric redox regulation and TG2-mediated disease pathologies.
Tonya Zeczycki, PhD - Associate Professor & Director, BSOM's Mass Spectrometry Core Facilities, East Carolina University
2:30 - 3:30 Talk: Characterization and Control Strategy for an ADC.
Jesse Coe - Associate Director, Business Development, KBI Biopharma